The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Decreased levels of serum exosomal miR‐638 predict poor prognosis in hepatocellular carcinoma
Abstract
Currently available studies have implicated that exosome‐delivered microRNAs (miRNAs) play crucial roles in human cancer. However, the association of serum exosomal miR‐638 and hepatocellular carcinoma (HCC) remains largely unknown. We aim to investigate the expression of exosomal miR‐638 in serum of HCC patients and its prognostic role in this deadly disease. Kaplan‐Meier and Cox regression analyses were used to determine the survival of patients histologically diagnosed with HCC. Reduced levels of exosomal miR‐638 in serum samples from patients with HCC were identified by real‐time PCR. Negative association of serum exosomal miR‐638 with tumor size, vascular infiltration, and TNM stage was observed in HCC patients. Besides, the proliferation of Huh7 and SMCC7721 HCC cells were significantly inhibited when miR‐638 was over‐expressed in these cells. In addition, HCC patients with lower levels of serum exosomal miR‐638 had poor overall survival than those with higher levels of exosomal miR‐638 in serum. Our study strongly suggests that serum exosome‐delivered miR‐638 may serve as a novel circulating biomarker for HCC. Downregulation of miR‐638 predicts poor prognosis for patients with HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs in cancer: biomarkers, functions and therapy
Hayes, J., Peruzzi, P. P., & Lawler, S. (2014) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2014.06.005 · Cited by 2,049
Endogenous RNAs modulate microRNA sorting to exosomes and transfer to acceptor cells.
Squadrito, M. L., Baer, C., Burdet, F., Maderna, C., Gilfillan, G. D., Lyle, R., Ibberson, M., & De Palma, M. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.07.035 · Cited by 604
Circulating microRNAs as emerging non-invasive biomarkers for gliomas
Santangelo, A., Tamanini, A., Cabrini, G., & Dechecchi, M. C. (2017) · Annals of Translational Medicine · doi:10.21037/atm.2017.06.15 · Cited by 36
Cited by
Roles and mechanisms of exosomal non-coding RNAs in human health and diseases
Li, C., Ni, Y.-Q., Xu, H., Xiang, Q.-Y., Zhao, Y., Zhan, J.-K., He, J.-Y., Li, S., & Liu, Y.-S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00779-x · Cited by 406
Cancer-Derived Exosomes: Their Role in Cancer Biology and Biomarker Development
Kok, V. C., & Yu, C.-C. (2020) · International Journal of Nanomedicine · doi:10.2147/ijn.s272378 · Cited by 398
Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values
Dhama, K., Latheef, S. K., Dadar, M., Samad, H. A., Munjal, A., Khandia, R., Karthik, K., Tiwari, R., Yatoo, M. I., Bhatt, P., et al. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00091 · Cited by 321
Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma
Johnson, P., Zhou, Q., Dao, D. Y., & Lo, Y. M. D. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00620-y · Cited by 320
Exosomes and cancer - Diagnostic and prognostic biomarkers and therapeutic vehicle
Wang, X., Tian, L., Lu, J., & Ng, I. O.-L. (2022) · Oncogenesis · doi:10.1038/s41389-022-00431-5 · Cited by 275
Metadata
- Authors
- Shi, M., Jiang, Y., Yang, L., Yan, S., Wang, Y., & Lu, X.
- Venue
- Journal of Cellular Biochemistry
- Publisher
- Wiley
- Published
- 2018-03
- Volume
- 119
- Issue
- 6
- Pages
- 4711-4716
- ISSN
- 0730-2312 (ISSN-L)
- 1097-4644
- OpenAlex
- W2779328694
- Cited by
- 160
- References
- 3
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.